These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 14280312)

  • 21. PaxVax CVD 103-HgR single-dose live oral cholera vaccine.
    Levine MM; Chen WH; Kaper JB; Lock M; Danzig L; Gurwith M
    Expert Rev Vaccines; 2017 Mar; 16(3):197-213. PubMed ID: 28165831
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serological responses of cattle to Vibrio fetus vaccine as measured by the complement-fixation test and tube-agglutination test.
    AMELL VH; STOCKTON JJ
    Am J Vet Res; 1956 Oct; 17(65):626-9. PubMed ID: 13362772
    [No Abstract]   [Full Text] [Related]  

  • 23. [Serologic response in man to cholera vaccine].
    Di Tommaso I
    Ann Sclavo; 1973; 15(4):445-52. PubMed ID: 4788453
    [No Abstract]   [Full Text] [Related]  

  • 24. Further studies on the cholera toxin and antitoxin.
    Ungar J; Stanić M; Varallyay SJ; Chariatte N
    Prog Immunobiol Stand; 1970; 4():583-9. PubMed ID: 4099025
    [No Abstract]   [Full Text] [Related]  

  • 25. Construction of novel vaccine strains of Vibrio cholerae co-expressing the Inaba and Ogawa serotype antigens.
    Lebens M; Karlsson SL; Källgård S; Blomquist M; Ekman A; Nygren E; Holmgren J
    Vaccine; 2011 Oct; 29(43):7505-13. PubMed ID: 21807059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. EFFECTS OF CHOLERA VACCINATION ON CLINICAL SYMPTOMS' OF EL-TOR VIBRIO INFECTION.
    CHAN YP; SUN TT; TSAI SY; WONG CC
    Tsa Chih Gaoxiong Yi Xue Yuan Tong Xue Hui; 1964 Feb; 63():80-4. PubMed ID: 14201560
    [No Abstract]   [Full Text] [Related]  

  • 27. [Ferric ammonium citrate as virulence-enhancing agent in the toxicity test of Vibrio cholerae and the potency assay of cholera vaccine].
    Tsai MY; Lu CH
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1989 Feb; 22(1):75-81. PubMed ID: 2791724
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evidence for CVD 103-HgR as an effective single-dose oral cholera vaccine.
    Jackson SS; Chen WH
    Future Microbiol; 2015; 10(8):1271-81. PubMed ID: 26228388
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cholera toxin-B (ctxB) antigen expressing Salmonella Typhimurium polyvalent vaccine exerts protective immune response against Vibrio cholerae infection.
    Vishwakarma V; Sahoo SS; Das S; Ray S; Hardt WD; Suar M
    Vaccine; 2015 Apr; 33(15):1880-9. PubMed ID: 25701672
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomized, controlled study of the safety and immunogenicity of Peru-15, a live attenuated oral vaccine candidate for cholera, in adult volunteers in Bangladesh.
    Qadri F; Chowdhury MI; Faruque SM; Salam MA; Ahmed T; Begum YA; Saha A; Alam MS; Zaman K; Seidlein LV; Park E; Killeen KP; Mekalanos JJ; Clemens JD; Sack DA;
    J Infect Dis; 2005 Aug; 192(4):573-9. PubMed ID: 16028125
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FOWL CHOLERA: COMPARISON OF SEROLOGIC AND IMMUNOGENIC RESPONSES OF CHICKENS AND TURKEYS.
    HEDDLESTON KL; WATKO LP
    Avian Dis; 1965 Aug; 9(3):367-76. PubMed ID: 14340901
    [No Abstract]   [Full Text] [Related]  

  • 32. The oral cholera vaccine Shanchol™ when stored at elevated temperatures maintains the safety and immunogenicity profile in Bangladeshi participants.
    Saha A; Khan A; Salma U; Jahan N; Bhuiyan TR; Chowdhury F; Khan AI; Khanam F; Muruganandham S; Reddy Kandukuri S; Singh Dhingra M; Clemens JD; Cravioto A; Qadri F
    Vaccine; 2016 Mar; 34(13):1551-1558. PubMed ID: 26896684
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune responses following killed whole vibrio-B subunit oral cholera vaccine in human volunteers.
    Pitisuttithum P; Migasena S; Suntharasamai P; Supanaranond W; Desakorn V; Prayurahong B
    Southeast Asian J Trop Med Public Health; 1989 Jun; 20(2):201-5. PubMed ID: 2609209
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Live attenuated oral cholera vaccines.
    Ryan ET; Calderwood SB; Qadri F
    Expert Rev Vaccines; 2006 Aug; 5(4):483-94. PubMed ID: 16989629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Studies on the efficacy of cholera vaccination in a population sample of Bari].
    Barbuti S; Iandolo E; Leogrande G; Rizzo G; Jatta E; Di Bari C
    Ann Sclavo; 1975; 17(3):489-99. PubMed ID: 1230049
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of lipopolysaccharide-mimicking peptides and their immunoprotectivity against Vibrio cholerae serogroup O1.
    Mohammad Pour Ghazi F; Gargari SL
    J Pept Sci; 2016 Nov; 22(11-12):682-688. PubMed ID: 27766741
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation Platform.
    Liao J; Gibson JA; Pickering BS; Watnick PI
    mSphere; 2018 Jun; 3(3):. PubMed ID: 29875145
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Ascaris lumbricoides: heterogeneity in ABO epithopes expression].
    Ponce-León P; Foresto P; Valverde J
    Invest Clin; 2006 Dec; 47(4):385-93. PubMed ID: 17176906
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cholera vaccine field trials in east Pakistan. 1. Reaction and antigenicity studies.
    Benenson AS; Joseph PR; Oseasohn RO
    Bull World Health Organ; 1968; 38(3):347-57. PubMed ID: 5302328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune responses following one and two doses of the reformulated, bivalent, killed, whole-cell, oral cholera vaccine among adults and children in Kolkata, India: a randomized, placebo-controlled trial.
    Kanungo S; Paisley A; Lopez AL; Bhattacharya M; Manna B; Kim DR; Han SH; Attridge S; Carbis R; Rao R; Holmgren J; Clemens JD; Sur D
    Vaccine; 2009 Nov; 27(49):6887-93. PubMed ID: 19761838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.